Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Feds to revamp bioterrorism and flu plans

Federal officials say they will revamp strategies for dealing with bioterrorism and pandemic flu because efforts to develop medical solutions have lagged, the Los Angeles Times reports. They "announced a $1.9-billion makeover of the system for identifying and manufacturing drugs and vaccines for public health emergencies." The makeover includes plans to hasten manufacturing time and improve surveillance to detect such threats more quickly.

21 Aug 2010

ActiveCare announces capital raise commitment, balance sheet restructuring

ActiveCare, Inc., a biotelematic technology company that specializes in products and services that help seniors manage and control their health and wellbeing while reducing overall costs to the healthcare industry, announced a capital raise commitment and balance sheet restructuring.

21 Aug 2010

First Edition: August 20, 2010

Today's headlines include articles on health insurance for college students, new plans to overhaul the government's bioterror and flu preparations, changes in store for health care for the homeless and a look at the new high risk insurance plans.

20 Aug 2010

Bavarian Nordic comments on Obama Administration's revised strategy for medical countermeasures

Bavarian Nordic A/S -- a leading industrial biotechnology company and long-term collaborator with the U.S. Government on the development of vaccines for the protection against biological threats, today commented on the Obama Administration's revised strategy for development, procurement and stockpiling of medical countermeasures.

20 Aug 2010

Bioniche provides update on Urocidin clinical development program for non-muscle-invasive bladder cancer

Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today provided an update on the clinical development program for its proprietary product for non-muscle-invasive bladder cancer - Urocidin.

20 Aug 2010

Quality issue roundup: J & J revamping controls; The odds for orthopedic surgery; Automatic prescription refills and patient compliance

The New York Times: Johnson & Johnson has said it will "revamp its quality controls, creating a single framework for its drug, medical device and consumer health care divisions." The move comes after the drugmaker saw a number of recalls of its medicines, such as Tylenol and Motrin, as well as probes by a congressional committee and the FDA into actions at its McNeil Consumer Healthcare subsidiary.

20 Aug 2010

MicroAire acquires Endotine fixation systems for facial aesthetic surgery

MicroAire Surgical Instruments is pleased to announce the acquisition of Endotine® bioabsorbable, multi-point, soft-tissue fixation systems for facial aesthetic surgery.

20 Aug 2010

Metagenics announces acquisition of Catalina Lifesciences

Metagenics, Inc., a San Clemente, California-based life sciences company, today announced its acquisition of Catalina Lifesciences, Inc., the Irvine, California-based maker of Bariatric Advantage.

20 Aug 2010

Neovasc revenue increases 60% for second quarter 2010

Neovasc Inc., today announced financial results for the three and six months ended June 30, 2010. "In this most recent quarter Neovasc continued to demonstrate robust year-over-year revenue growth from sales of our biological tissue and consulting services businesses," said Alexei Marko, chief executive officer of Neovasc.

19 Aug 2010

MannKind Corporation announces pricing of Senior Convertible Notes due 2015

MannKind Corporation today announced the pricing of its previously announced offering of $100 million aggregate principal amount of Senior Convertible Notes due 2015 (the "Notes"). The Notes will be offered and sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), by the financial institutions that are the initial purchasers of the notes.

19 Aug 2010

PharmaVentures announces global expansion of PharmaDeals Agreements

PharmaVentures, the company behind the PharmaDeals(R) range of business information, announced today the expansion of its PharmaDeals Agreements coverage that includes exclusive interviews with deal makers around the world. The announcement follows major enhancement of its dedicated, market leading platform delivering deal data and information to the pharmaceutical and biotechnology sector.

19 Aug 2010

Two-day LEAN training course for healthcare professionals

The two-day course is a didactic and hands-on introduction to LEAN management philosophy and manufacturing-based work rules and tools designed to prepare physicians, administrators, and technical support staff for the realities and potential successes of practicing in a LEAN environment. The sessions are not only oriented to laboratory medicine but also adapted to the processes encountered in clinical services as well.

19 Aug 2010

Cannabis Science signs manufacturing and development license with RockBrook

Cannabis Science Inc. a pioneering US biotech company developing pharmaceutical cannabis products, announces that on August 18, 2010, Cannabis Science signed with RockBrook Inc., its first manufacturing and development license for the Cannabis Science Brand of Pharmaceutical Products for the State of Colorado.

19 Aug 2010

AdvanSource Biomaterials 2010 fiscal first quarter revenue increases 11.8%

AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced financial results for its fiscal 2011 first quarter ended June 30, 2010.

19 Aug 2010

Thermo Fisher Scientific opens Technology Center in Shanghai

Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has opened a Technology Center in Shanghai, building on its engineering and development capabilities to meet the specific needs of customers in China. The Center houses engineers and support staff focused on developing a robust product pipeline to serve China-based customers across a range of industries, in particular, life sciences, environmental monitoring and consumer product safety.

From Thermo Fisher Scientific Inc. 18 Aug 2010

Regenicin acquires worldwide exclusive license to know-how technology

Regenicin, Inc., a development stage biotechnology company, announced today that it has completed an initial $3.25 million funding in conjunction with its acquisition of a worldwide exclusive license to know-how technology controlled by Lonza Walkersville ("Lonza Agreement").

18 Aug 2010

Midatech Group, MonoSol Rx file patent to enable commercialization of drug delivery technology

Midatech Group Ltd., a global leader for the design, development, synthesis and manufacture of nanomedicines, and MonoSol Rx, the leader in developing and manufacturing pharmaceutical films based on its proprietary PharmFilm drug delivery technology, today announced the filing of a provisional US patent application for "Nanoparticle Film Delivery Systems." The applications submitted to the United States Patent and Trademark Office (USPTO) relate to therapeutic uses of nanoparticle-based proteins and peptides delivered in pharmaceutical films.

18 Aug 2010

Varian to showcase new Gated RapidArc technology at 2010 CHINA-HOSPEQ exhibition

Varian Medical Systems, Inc. will showcase the company's new Gated RapidArc technology on its Trilogy® machine with advanced motion management capabilities at the 2010 CHINA-HOSPEQ exhibition being held in Beijing August 19-21 by China's Ministry of Health. Varian, the world's leading manufacturer of medical technology for treating cancer and a premier supplier of X-ray imaging technology, will also exhibit its software for planning and for managing radiation therapy treatments.

18 Aug 2010

Pisgah Labs receives Notice of Allowance for new patent relating to thyroid hormone drugs

Today, Pisgah Labs, Inc. received a Notice of Allowance from the United States Patent and Trademark office for an important new technology patent addressing global stability problems of thyroid hormone drugs.

17 Aug 2010

Elite Pharmaceuticals reports decrease in manufacturing revenue for fiscal first quarter

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and controlled release product formulations, announced results for the fiscal first quarter ended June 30, 2010.

17 Aug 2010

Manufacturing News and Research

Further Reading

Feds to revamp bioterrorism and flu plans

ActiveCare announces capital raise commitment, balance sheet restructuring

First Edition: August 20, 2010

Bavarian Nordic comments on Obama Administration's revised strategy for medical countermeasures

Bioniche provides update on Urocidin clinical development program for non-muscle-invasive bladder cancer

Quality issue roundup: J & J revamping controls; The odds for orthopedic surgery; Automatic prescription refills and patient compliance

MicroAire acquires Endotine fixation systems for facial aesthetic surgery

Metagenics announces acquisition of Catalina Lifesciences

Neovasc revenue increases 60% for second quarter 2010

MannKind Corporation announces pricing of Senior Convertible Notes due 2015

PharmaVentures announces global expansion of PharmaDeals Agreements

Two-day LEAN training course for healthcare professionals

Cannabis Science signs manufacturing and development license with RockBrook

AdvanSource Biomaterials 2010 fiscal first quarter revenue increases 11.8%

Thermo Fisher Scientific opens Technology Center in Shanghai

Regenicin acquires worldwide exclusive license to know-how technology

Midatech Group, MonoSol Rx file patent to enable commercialization of drug delivery technology

Varian to showcase new Gated RapidArc technology at 2010 CHINA-HOSPEQ exhibition

Pisgah Labs receives Notice of Allowance for new patent relating to thyroid hormone drugs

Elite Pharmaceuticals reports decrease in manufacturing revenue for fiscal first quarter

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News